These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9493875)
41. Postnatal decrease of sodium current density in rat pituitary melanotropes following the onset of dopaminergic innervation. López-Santiago LF; Gómora JC; Cota G Neurosci Lett; 2001 Nov; 315(3):137-40. PubMed ID: 11716982 [TBL] [Abstract][Full Text] [Related]
42. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists. Mittleman G; Rosner AL; Schaub CL J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779 [TBL] [Abstract][Full Text] [Related]
43. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors. Zackheim JA; Abercrombie ED Brain Res Bull; 2001 Apr; 54(6):603-7. PubMed ID: 11403986 [TBL] [Abstract][Full Text] [Related]
44. Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats. Wilkerson A; Levin ED Neuroscience; 1999 Mar; 89(3):743-9. PubMed ID: 10199609 [TBL] [Abstract][Full Text] [Related]
45. Dopamine acting through D2 receptors modulates the expression of PSA-NCAM, a molecule related to neuronal structural plasticity, in the medial prefrontal cortex of adult rats. Castillo-Gómez E; Gómez-Climent MA; Varea E; Guirado R; Blasco-Ibáñez JM; Crespo C; Martínez-Guijarro FJ; Nácher J Exp Neurol; 2008 Nov; 214(1):97-111. PubMed ID: 18718470 [TBL] [Abstract][Full Text] [Related]
46. D2-like dopamine receptor mediates dopaminergic or gamma-aminobutyric acidergic inhibition of melanotropin-releasing hormone release from the pars intermedia in frogs (Rana nigromaculata). Tonosaki Y; Nishiyama K; Honda T; Ozaki N; Sugiura Y Endocrinology; 1995 Dec; 136(12):5260-5. PubMed ID: 7588269 [TBL] [Abstract][Full Text] [Related]
47. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors. Siuciak JA; Fujiwara RA Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923 [TBL] [Abstract][Full Text] [Related]
48. Neurochemical evidence of dopamine release by lateral olivocochlear efferents and its presynaptic modulation in guinea-pig cochlea. Gáborján A; Lendvai B; Vizi ES Neuroscience; 1999 Apr; 90(1):131-8. PubMed ID: 10188940 [TBL] [Abstract][Full Text] [Related]
49. A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule. Izzo E; Orsini C; Koob GF; Pulvirenti L Pharmacol Biochem Behav; 2001 Apr; 68(4):701-8. PubMed ID: 11526967 [TBL] [Abstract][Full Text] [Related]
50. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat. Caine SB; Geyer MA; Swerdlow NR Neuropsychopharmacology; 1995 Apr; 12(2):139-45. PubMed ID: 7779242 [TBL] [Abstract][Full Text] [Related]
51. Reevaluation of PNU-99194A discriminative stimulus effects: potentiation by both a D2 antagonist and a D3/D2 agonist. Baker LE; Prus AJ Pharmacol Biochem Behav; 2002 Nov; 73(4):753-8. PubMed ID: 12213519 [TBL] [Abstract][Full Text] [Related]
52. Endogenous activation of dopamine D2 receptors regulates dopamine release in the fish retina. Wang Y; Harsanyi K; Mangel SC J Neurophysiol; 1997 Jul; 78(1):439-49. PubMed ID: 9242292 [TBL] [Abstract][Full Text] [Related]
53. [Effect of intrathecal injection of dopamine receptor agonists/antagonists on pain and acupuncture analgesia in rats]. Gao X; Xin BM; Zhu CB; Wu GC; Xu SF Sheng Li Xue Bao; 1998 Feb; 50(1):43-8. PubMed ID: 11324516 [TBL] [Abstract][Full Text] [Related]
54. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. Li J; Guo Y; Schroeder FA; Youngs RM; Schmidt TW; Ferris C; Konradi C; Akbarian S J Neurochem; 2004 Sep; 90(5):1117-31. PubMed ID: 15312167 [TBL] [Abstract][Full Text] [Related]
55. Evidence for a direct negative coupling between dopamine-D2 receptors and PLC by heterotrimeric Gi1/2 proteins in rat anterior pituitary cell membranes. Rasolonjanahary R; Gerard C; Dufour MN; Homburger V; Enjalbert A; Guillon G Endocrinology; 2002 Mar; 143(3):747-54. PubMed ID: 11861492 [TBL] [Abstract][Full Text] [Related]
56. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats. Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034 [TBL] [Abstract][Full Text] [Related]
57. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs. Cho S; Neff NH; Hadjiconstantinou M Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833 [TBL] [Abstract][Full Text] [Related]